medigraphic.com
ISSN 1817-5996 (Electronic)

2011, Number 17

<< Back Next >>

Rev Cub de Reu 2011; 13 (17)

Coexistencia de Herpes zoster y Lupus eritematoso sistémico, una asociación frecuente

Hernández MY, Cruz GY, Mirabal SH

Language: Spanish
References: 36
Page:
PDF size: 105.64 Kb.


ABSTRACT

No abstract.


REFERENCES

  1. Doria A, Briani C. Lupus: improving long-term prognosis.Lupus. 2008; 17: 166- 70. [ Links ]

  2. Trager J, Ward MM. Mortality and causes of death in systemic lupus erythematosus. Curr Opin Rheumatol. 2001; 13: 345- 51. [ Links ]

  3. Merock A, Nossent H. Damage accumulation in systemic lupus erythematosus and its relation to disease activity and morality. J Rheumatol. 2006; 33: 1570- 7. [ Links ]

  4. Gordon C. Long-term complications of systemic lupus erythematosus. Rheumatology. 2002; 41: 1095-100. [ Links ]

  5. Mok CC, Lee K W, Ho CTK, Lau CS, Wong RWS. A prospective study of survival and prognostic indicator of systemic lupus erythematosus in a southern Chinese population. Rheumatology. 2000; 39: 399- 406. [ Links ]

  6. Bernatzky S, Boivin JF, Joseph L. Mortality in systemic lupus erythematosus. Arthritis Rheum. 2006; 54: 2550- 7. [ Links ]

  7. Bastian HM, Alarcon GS,Roseman JM, McGwin G, Vila LM, Fessler BJ, et al. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA) XL II : factors predictive of new or worsening proteinuria. Rheumatology. 2007; 46: 683- 9. [ Links ]

  8. Ziakas PD, Dafni UG, Giannouli S, Tzioufas AG, Voulgarelis M. Thrombocytopaenia in lupus as a marker of adverse outcome-seeking Ariadne's thread. Rheumatology. 2006; 45: 1261- 5. [ Links ]

  9. Mok CC, Mak A, Chu WP, To CH, Wong SN. Long-term survival of southern Chinese patients with systemic lupus erythematosus: a prospective study of all age-groups. Medicine (Baltimore). 2005 Jul; 84(4):218-24. [ Links ]

  10. Doria A, Iaccarino L, Ghirardello A, Zampieri S, Arienti S, Sarzi- Puttini P, et al. Long-term prognosis and causes of death in systemic lupus erythematosus. Am J Med. 2006; 119:700- 6. [ Links ]

  11. Gladman DD, Urowitz MB. Morbidity in systemic lupus erythematosus. J Rheumatol. 1987; 14 Suppl 13:223-6.

  12. Petri M, Perez-Gutthann S, Longenecker JC, Hochberg MC. Morbidity of systemic lupus erythematosus: Role of race and socioeconomic status. Ann J Med. 1991; 91: 345- 53.

  13. Vujacich C, Poggi E, Cecchini D, Luchetti P, Stamboulian D. Herpes zoster: Epidemiología y clínica. Medicina (B. Aires) 2008; 68(2): 125-128. Links

  14. Minami S, Costa M, Antônio S, Chahade W. Distrofia simpática reflexa pós herpes zoster. Rev. Bras. Reumatol. 2004 Aug; 44(4): 301-304. Links

  15. Perales J, Sanz M, Sánchez G, Arana T, Cenarro T, García C. Herpes zoster en la consulta de Atención Primaria y su posible relación con varicelas precoces. Rev Pediatr Aten Primaria. 2009; 11 (supl. 17): Links

  16. Téllez N, Jacas A, Estrada R, López N, Ge Grant A. Herpes zoster oftálmico en pacientes con cáncer de pulmón. MEDISAN 2009; 13(3): Links

  17. Larralde M, Gomar B, Yulitta H. Varicela y herpes zoster: informe de un caso. Arch. argent. pediatr. 2007; 105(4): 339-341. Links

  18. Petri M, Genovese M. Incidence of and risk factors for hospitalizations in systemic lupus erythematosus: a prospective study of the Hopkins Lupus Cohort. J Rheumatol. 1992; 19: 1559- 65.

  19. Formiga Pérez F, Moga Sampere I, Canet González R, Pac Ferraz M, Mitjavila Villero F, Fernández Nogués F. Infection and systemic lupus erythematosus: analisis of a series of 145 patients. Rev Clin Esp. 1993; 193:105-9.

  20. Sanz B, Quintana J, Martín I. Manejo del episodio agudo de herpes zoster y la neuralgia post-herpética. Medifam. 2002; 12(3): 27-39. Links

  21. McDonald JR, Zeringue AL, Caplan L, Ranganathan P, Xian H, Burroughs TE, Fraser VJ, Cunningham F, Eisen SA. Herpes zoster risk factors in a national cohort of veterans with rheumatoid arthritis. Clin Infect Dis. 2009; 48(10): 1364-71.

  22. Chen H, Chen YM, Chen TJ, Lan JL, Lin CH, Chen DY. Risk of herpes zoster in patients with systemic lupus erythematosus: a three-year follow-up study using a nationwide population-based cohort. Clinics. 2011; 66(7): 1177-1182.

  23. Nagel MA, Choe A, Cohrs RJ, Traktinskiy I, Sorensen K, Mehta SK, Pierson DL, Tyring SK, Haitz K, Digiorgio C, Lapolla W, Gilden D. Persistence of varicella zoster virus DNA in saliva after herpes zoster.J Infect Dis. 2011; 204(6): 820-4.

  24. Johnson RW, Bouhassira D, Kassianos G, Leplège A, Schmader KE, Weinke T. The impact of herpes zoster and post-herpetic neuralgia on quality-of-life.BMC Med. 2010; 8: 37.

  25. Blanco FJ, Gómez-Reino JJ, De La Maza J, Corrales A, Rodriguez-Valverde V, Rosas JC, et al. Survival analysis of 306 European Spanish patients with systemic lupus erythematosus. Lupus. 1998; 7: 159- 63.

  26. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, Aydintug AO, et al. Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1.000 patients. European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore). 1999; 78: 167- 75.

  27. Rosner S, Ginzler EM, Diamond HS, Weiner M, Schlesinger M, Fries JF, et al. A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death. Arthritis Rheum. 1982; 25:612-7.

  28. Ernst P, Dell'Aniello S, Mikaeloff Y, Suissa S. Risk of herpes zoster in patients prescribed inhaled corticosteroids: a cohort study.MC Pulm Med. 2011; 11: 59.

  29. Sáez-Llorens X, Yogev R, Arguedas A, Rodriguez A, Spigarelli MG, De León Castrejón T, Bomgaars L, Roberts M, Abrams B, Zhou W, Looby M, Kaiser G, Hamed K. Pharmacokinetics and safety of famciclovir in children with herpes simplex or varicella-zoster virus infection. Antimicrob Agents Chemother. 2009; 53(5): 1912-20.

  30. Sanz Pozo B, Quintana Gómez J L, Martín González I. Manejo del episodio agudo de herpes zoster y la neuralgia post-herpética. Medifam. 2002 12(3): 27-39.

  31. Drolet M, Brisson M, Schmader KE, Levin MJ, Johnson R, Oxman MN, Patrick D, Blanchette C, Mansi JA. The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study. CMAJ. 2010; 182(16): 1731-6.

  32. Cao H, Zhu C, Liu J, Wet cupping therapy for treatment of herpes zoster: a systematic review of randomized controlled trials.Altern Ther Health Med. 2010; 16(6): 48-54.

  33. Fleckenstein J, Kramer S, Hoffrogge P, Thoma S, Lang PM, Lehmeyer L, Schober GM, Pfab F, Ring J, Weisenseel P, Schotten KJ, Mansmann U, Irnich D. Acupuncture in acute herpes zoster pain therapy (ACUZoster) - design and protocol of a randomised controlled trial. BMC Complement Altern Med. 2009; 9: 31.

  34. Uscategui T, Doree C,; Chamberlain IJ, Burton MJ. Corticosteroids as adjuvant to antiviral treatment in Ramsay Hunt syndrome (herpes zoster oticus with facial palsy) in adults. Cochrane Database Syst Rev. 2008; (3): CD006852.

  35. Opstelten W, Eekhof J, Neven AK, Verheij T. Treatment of herpes zoster. Can Fam Physician. 2008; 54(3): 373-7.

  36. Bennett GJ, Watson CP. Herpes zoster and postherpetic neuralgia: past, present and future. Pain Res Manag. 2009; 14(4): 275-82.




2020     |     www.medigraphic.com